Laurent Meijer
ORCID: 0000-0003-3511-4916Also affiliated with Station Biologique de Roscoff, Avid Bioservices (United States), ManRos Therapeutics (France)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 6 papers. Top paper: “Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer’s Disease and Down Syndrome”.
Emilie Chrétien, Denis Ravel, Laurent Meijer
Saïd Akli, Cansu Karakaş, Min Jin Ha, Natalie W. Fowlkes, Yoshitsugu Mitani +8 more
Lucía Maure-Blesa, Beau M. Ances, Lisi Flores Aguilar, Sigan L. Hartley, Jason Hassenstab +54 more
Keehn Strange, Rahul Telange, Ailan Guo, Heather Hatch, Amin Sobh +16 more
A. P. Young, Kaitlyn L. Wintruba, Alexander J Eichert, Klara Siejda, Dennon Hoenig +10 more
Synthesis, biological evaluation and molecular docking studies of 4-arylidene-2-phenyloxazol-5(4H)-one derivatives as inhibitors of dual-specificity tyrosine phosphorylation-regulated kinases and Cdc2-like kinases
Sandeep Jain, N S Hari Moorthy, Elangovan Manivannan, Laurent Meijer, Piyush Trivedi +1 more